BRIEF published on 06/15/2026 at 19:35, 3 days 11 hours ago Oxurion: Exagis adopted by Pierre Fabre Biopharmaceutical Clinical Data Oxurion Exaggerate Pierre Fabre
BRIEF published on 06/15/2026 at 19:35, 3 days 11 hours ago Oxurion's Exagis Platform Gains Major Market Validation with Pierre Fabre Laboratories Data Management Pharmaceutical Oxurion Pierre Fabre Exagis Platform
PRESS RELEASE published on 06/15/2026 at 19:30, 3 days 11 hours ago Major market validation: Pierre Fabre Laboratories uses Oxurion's Exagis Platform Oxurion NV announces Pierre Fabre Laboratories utilizing Exagis clinical data management platform by Axiodis CRO, enhancing efficiency and compliance. Exagis adapts to various study configurations Oxurion NV Clinical Data Management Axiodis CRO Exagis Pierre Fabre Laboratories
BRIEF published on 06/10/2026 at 18:05, 8 days 13 hours ago Oxurion receives a transparency notification from Atlas Special Opportunities II LLC Shares Transparency Euronext Brussels Oxurion Atlas Special Opportunities II LLC
BRIEF published on 06/10/2026 at 18:05, 8 days 13 hours ago Oxurion Receives Notification on Shareholding Change Shares Transparency Notification Belgium Atlas Special Opportunities Oxurion
PRESS RELEASE published on 06/10/2026 at 18:00, 8 days 13 hours ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding crossing the threshold. Oxurion is a technology-enabled clinical research company Clinical Research Transparency Notification Shareholding Oxurion NV Atlas Special Opportunities II, LLC
BRIEF published on 06/08/2026 at 21:05, 10 days 10 hours ago Oxurion announces its software strategy with Exagis Growth Strategy Clinical Research Software Oxurion Exaggerate
BRIEF published on 06/08/2026 at 21:05, 10 days 10 hours ago Oxurion Unveils Software-Driven Growth Strategy with Exagis Oxurion Clinical Data Management Exagis Software Strategy EClinical Platform
PRESS RELEASE published on 06/08/2026 at 21:00, 10 days 10 hours ago Oxurion launches a software-driven growth strategy with Exagis Oxurion NV announces the software-driven growth strategy launch centered on Exagis, its proprietary clinical research platform. The platform evolves into a broad CDMS commercially serving clinical development market Oxurion NV Exagis Clinical Research Platform Software-driven Growth Strategy CDMS
BRIEF published on 06/03/2026 at 18:05, 15 days 13 hours ago Oxurion Announces the Results of its Annual General Meeting Pharmaceutical Investments General Assembly Results Oxurion
Published on 06/19/2026 at 04:30, 2 hours 47 minutes ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 5 hours 57 minutes ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 6 hours 10 minutes ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 00:00, 7 hours 17 minutes ago Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/19/2026 at 07:00, 17 minutes ago HORNBACH Group delivers strong start to new financial year – net sales up 4.9% in Q1 2026/27
Published on 06/19/2026 at 06:59, 18 minutes ago Zehnder Group: Introduction of a divisional organizational structure
Published on 06/19/2026 at 06:00, 1 hour 17 minutes ago Hong Kong universities scale global heights, cementing education hub status
Published on 06/19/2026 at 03:35, 3 hours 42 minutes ago From Father's Day to Summer Getaways: How Oxygen Support Helps Protect Health During Europe's Peak Travel Season
Published on 06/18/2026 at 18:00, 13 hours 17 minutes ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 13 hours 32 minutes ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 13 hours 38 minutes ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026
Published on 06/18/2026 at 09:06, 22 hours 11 minutes ago Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
